Skip to main content
Premium Trial:

Request an Annual Quote

Report: Athersys Ponders Move to NC

NEW YORK, Nov. 27-Functional genomics company Athersys may pull up its roots in Ohio and move to Durham, N.C., according to a report in the Business Journal of Raleigh/Durham.

In October, the Duke University Institute for Genome Sciences and Policy hired Athersys collaborator and scientific advisor Huntington Willard as its new director, prompting discussions of the move. Willard is currently director and president of the research institute of the University Hospitals of Cleveland.

 

Athersys has about 130 employees, and collaborates with both Case Western Reserve University and the Cleveland Clinic Foundation.

 

The company markets a gene expression tool, RAGE, has developed a gene therapy technique to create artificial human chromosomes, and ultimately plans to develop proteins, peptides, and antibody treatments.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.